American biotech firm Moderna said on May 26 (2021) that clinical trials have shown that its Covid-19 vaccine is “highly effective” in adolescents aged 12 to 17 years old.
The company will seek healthcare regulators’ approval next month (June 2021).
Already a subscriber? Log in.
Get 30% off with our ads free Premium Plan!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!